[1] OLSEN M H, ANGELL S Y, ASMA S, et al. A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension [J]. Lancet (London, England), 2016, 388(10060): 2665-712.
[2] LOZANO R, NAGHAVI M, FOREMAN K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 [J]. Lancet (London, England), 2012, 380(9859): 2095-128.
[3] LU J, LU Y, WANG X, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from 1.7 million adults in a population-based screening study (China PEACE Million Persons Project) [J]. Lancet (London, England), 2017, 390(10112): 2549-58.
[4] TREVISOL D J B, MOREIRA L B, KERKHOFF A, et al. Health-related quality of life and hypertension: a systematic review and meta-analysis of observational studies [J]. Journal of Hypertension: February 2011, 29(2): 179-88.
[5] QIN Y, GUO Y, TANG Y, et al. Impact of hypertension on health-related quality of life among different age subgroups in Shanghai: the subpopulation treatment effect pattern plot analysis [J]. Journal of human hypertension, 2018, 33(1):78-86.
[6] KLOCEK M, KAWECKA-JASZCZ K. Quality of life in patients with arterial hypertension [J]. 2003, 60(2): 92-100.
[7] WANG R, ZHAO Y, HE X, et al. Impact of hypertension on health-related quality of life in a population-based study in Shanghai, China [J]. Public health, 2009, 123(8): 534-9.
[8] National Bureau of Statistics. http://data.stats.gov.cn/index.htm[DB/OL]. 2020.
[9] LI H, MENG Q, SUN X, et al. Prevalence, awareness, treatment, and control of hypertension in rural China: results from Shandong Province [J]. Journal of hypertension, 2010, 28(3): 432-8.
[10] PETER M.FAYERS D M. Quality of life--The assessment, analysis and reporting of patient reported outcomes, third edition [M]. WILEY Blakwell, 2016.
[11] FISHWICK D, LEWIS L, DARBY A, et al. Determinants of health-related quality of life among residents with and without COPD in a historically industrialised area [J]. International Archives of Occupational & Environmental Health, 2014, 88(6): 1-7.
[12] LIU K, HE L, TANG X, et al. Relationship between menopause and health-related quality of life in middle-aged Chinese women: a cross-sectional study [J]. BMC Women's Health, 2014, 14(1): 7.
[13] YANG Z, ., LI W, ., TU X, ., et al. Validation and psychometric properties of Chinese version of SF-36 in patients with hypertension, coronary heart diseases, chronic gastritis and peptic ulcer [J]. International Journal of Clinical Practice, 2012, 66(10): 991-98.
[14] CARVALHO M V, SIQUEIRA L B, SOUSA A L, et al. The influence of hypertension on quality of life [J]. Arquivos Brasileiros De Cardiologia, 2013, 100(2): 164-74.
[15] AYDEMIR O, OZDEMIR C, KOROGLU E. The impact of co-morbid conditions on the SF-36: a primary-care-based study among hypertensives [J]. Archives of Medical Research, 2005, 36(2): 136-41.
[16] ROBINSON R. Cost-utility analysis [J]. Bmj British Medical Journal, 1993, 307(6908): 859-62.
[17] LEE M H, SO E S. Impact of hypertension-related comorbidity on health-related quality of life: a population-based survey in South Korea [J]. Asia-Pacific journal of public health, 2012, 24(5): 753-63.
[18] SALEEM F, HASSALI M A, SHAFIE A A. A cross-sectional assessment of health-related quality of life (HRQoL) among hypertensive patients in Pakistan [J]. Health expectations : an international journal of public participation in health care and health policy, 2014, 17(3): 388-95.
[19] ZHANG Y, ZHOU Z, GAO J, et al. Health-related quality of life and its influencing factors for patients with hypertension: evidence from the urban and rural areas of Shaanxi Province, China [J]. BMC health services research, 2016, 16:277.
[20] ZHANG L, GUO X, ZHANG J, et al. Health-related quality of life among adults with and without hypertension: A population-based survey using EQ-5D in Shandong, China [J]. Scientific reports, 2017, 7(1): 14960.
[21] EKWUNIFE O I, AGUWA C N, IGBOELI N U. Health Utilities Index Mark 3 (HUI3) demonstrated construct validity in a Nigerian population with hypertension [J]. Quality of Life Research, 2013, 22(2): 455-58.
[22] EKWUNIFE O I, AGUWA C N, ADIBE M O, et al. Health state utilities of a population of Nigerian hypertensive patients [J]. BMC research notes, 2011, 4:528.
[23] NGUYEN T-P-L, KRABBE P F M, NGUYEN T-B-Y, et al. Utilities of Patients with Hypertension in Northern Vietnam [J]. PloS one, 2015, 10(10): e0139560.
[24] National Bureau of Statistics of China.China Statistical Yearbook 2017 [in Chinese] [M]. China Statistics Press, 2017.
[25] National health commission of the People's Republic of China.Circular of the Ministry of Health on the Issuance of the National Standards for 《Basic Public Health Services(2009)》 [M].
[26] ASSOCIATION W M. World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects [J]. JAMA, 2013, 310(20): 2191-94.
[27] LIU L S. [2010 Chinese guidelines for the management of hypertension] [J]. Chinese Journal of Hypertension, 2011, 39(2): 579-615.
[28] J. J E W. SF-36 Health Survey:Manual & Interpretation Guide [M]. The health institute, New England Medical Centre Boston,Massachusetts., 1993.
[29] BRAZIER J, ROBERTS J, DEVERILL M. The estimation of a preference-based measure of health from the SF-36 [J]. Journal of health economics, 2002, 21(2): 271-92.
[30] STEL V, H.F, BUSKENS. Comparison of the SF-6D and the EQ-5D in patients with coronary heart disease [J]. Health & Quality of Life Outcomes, 2006, 4(1): 20.
[31] SAYAH F A, QIU W, XIE F, et al. Comparative performance of the EQ-5D-5L and SF-6D index scores in adults with type 2 diabetes [J]. Quality of Life Research An International Journal of Quality of Life Aspects of Treatment Care & Rehabilitation, 2017, 26(8): 2057.
[32] MCGHEE S M, BRAZIER J, LAM C L, et al. Quality-adjusted life years: population-specific measurement of the quality component [J]. Hong Kong medical journal = Xianggang yi xue za zhi, 2011, 17 (6): 17-21.
[33] LIANG Z Z, TIANTIAN; LIN,TENGFEI; LIU, LISHUN;WANG,BINYAN;. Health-related quality of life among rural men and women with hypertension: assessment by the EQ-5D-5L in Jiangsu, China [J]. Quality of Life Research, 2019,28, 2069–2080
[34] WEN L, QINGHUA Z, WUNONG Z, et al. Current Status of Active Aging of 381 Rural Seniors and Its Influence Factors [J]. Journal of Nursing(China),2019,26(15),41-45.
[35] LIU Z, ALBANESE E, LI S, et al. Chronic disease prevalence and care among the elderly in urban and rural Beijing, China - a 10/66 Dementia Research Group cross-sectional survey [J]. BMC public health, 2009, 9(1): 394.
[36] QIAN S. Aging and separation from children: The health implications of adult migration for elderly parents in rural China [J]. Demographic Research, 2019, 37:1761-92.
[37] XIAOBO W, LIQIN W, DIANWU L, et al. Analysis on hypertension KAP and influence factors in rural population [J]. China of journal public health, 2008, 24(3): 269-70.
[38] LI D, LV J, LIU F, et al. Hypertension burden and control in mainland China: Analysis of nationwide data 2003-2012 [J]. International journal of cardiology, 2015, 184:637-44.
[39] WONG C K H, MULHERN B. SF-6D population norms for the Hong Kong Chinese general population [J]. 2018, 27(9): 2349-59.
[40] FERREIRA L N, FERREIRA P L, PEREIRA L N, et al. Exploring the consistency of the SF-6D [J]. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 2013, 16(6): 1023-31.
[41] ZHOU Z L, ZHOU Z Y, DAN L I. Analyzing the Health-related Quality of Life of Urban and Rural Residents in Shaanxi: Estimation Based on the EQ-5D Value Sets [J]. Chinese Health Economics, 2015, 34(2): 13-16.
[42] ANDRADE J M, RIOS L R, TEIXEIRA L S, et al. [Influence of socioeconomic factors on the quality of life of elderly hypertensive individuals] [J]. Ciencia & saude coletiva, 2014, 19(8): 3497-504.
[43] BARDAGE C, ISACSON D G. Hypertension and health-related quality of life. an epidemiological study in Sweden [J]. Journal of clinical epidemiology, 2001, 54(2): 172-81.
[44] PAN Y, YING Y E, ZHU J, et al. Analysis of influencing factors on quality of life(QOL) of patients with hypertension by SF-36 scale [J]. Fudan University Journal of Medical Sciences, 2014, 41(2): 205-09.
[45] ARSLANTAS D, AYRANCI U, UNSAL A, et al. Prevalence of hypertension among individuals aged 50 years and over and its impact on health related quality of life in a semi-rural area of western Turkey [J]. Chinese medical journal, 2008, 121(16): 1524-31.
[46] L M, J A L, BENJAMIN E J E A. Evidence-based guidelines for cardiovascular disease prevention in women.American Heart Association scientific statement [J]. Arterioscler Thromb Vasc Biol, 2004, 24(3): 29-50.